학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 15건 | 목록 1~20
Academic Journal
Kemps PG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Woei-A-Jin FJSH; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Quint KD; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.; van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Naeije L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van Laar JAM; Section of Clinical Immunology and Allergology, Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Vanden Bempt I; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.; Koudijs MJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Vorderman RHP; Department of Biomedical Data Sciences, Sequencing Analysis Support Core, Leiden University Medical Center, Leiden, The Netherlands.; Stelloo E; Cergentis BV, a Solvias company, Utrecht, The Netherlands.; Swennenhuis JF; Cergentis BV, a Solvias company, Utrecht, The Netherlands.; Bruggink AH; Palga (Dutch Nationwide Pathology Databank), Houten, The Netherlands.; Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Diercks GFH; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Hauben E; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Tousseyn T; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Translational Cell and Tissue Research Laboratory, Catholic University of Leuven, Leuven, Belgium.; Cleven AHG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Halteren AGS; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Section of Clinical Immunology and Allergology, Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Hogendoorn PCW; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Academic Journal
Kemps PG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Baelde HJ; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Vorderman RHP; Sequencing Analysis Support Core, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Stelloo E; Cergentis BV, a Solvias Company, Utrecht, The Netherlands.; Swennenhuis JF; Cergentis BV, a Solvias Company, Utrecht, The Netherlands.; Szuhai K; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.; Lamers MH; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.; Kenkhuis B; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Al-Hussaini M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan.; Briaire-de Bruijn IH; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Lam SW; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Cleven AHG; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; van Noesel CJM; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; van Dijk MR; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Bruggink AH; Palga, Houten, The Netherlands.; van Laar JAM; Section Clinical Immunology, Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; von Deimling A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany.; van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Halteren AGS; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Section Clinical Immunology, Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Hogendoorn PCW; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
de Kanter JK; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Steemers AS; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Gonzalez DM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; van Ineveld RL; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Blijleven C; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: University of Copenhagen Copenhagen Denmark.; Groenen N; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Trabut L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Westera L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Beishuizen A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Rios AC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Holstege FCP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Brandsma AM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: Sanquin Blood Bank Amsterdam the Netherlands.; Margaritis T; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; van Boxtel R; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Kroeze E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Iaccarino I; Department of Pathology, Hematopathology Section and Lymph Node Registry, University of Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Kleisman MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Mondal M; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.; Centre for Genomics, Evolution and Medicine, Institute of Genomics, University of Tartu, Tartu, Estonia.; Beder T; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Khouja M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Höppner MP; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Brüggemann M; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Baldus CD; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Cario G; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.; Department of Pediatrics, Berlin-Frankfurt-Münster ALL Study Group Germany, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Bladergroen RS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Garnier N; Institut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon, France.; Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; Verdu-Amorós J; Department of Pediatric Hematology and Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA, Biomedical Research Institute, Valencia, Spain.; Sutton R; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.; Macintyre E; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, Centre National de la Recherche Scientifique, INSERM U1151, Institut Necker Enfants Malades, Paris, France.; Scholten K; Pediatric Hematology and Oncology, NHL-BFM Study Center, University Hospital Münster, Münster, Germany.; Arias Padilla L; Pediatric Hematology and Oncology, NHL-BFM Study Center, University Hospital Münster, Münster, Germany.; Burkhardt B; Pediatric Hematology and Oncology, NHL-BFM Study Center, University Hospital Münster, Münster, Germany.; Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.; den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.; Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.; Loeffen JLC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, University of Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Bonn, Germany.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Kroeze E; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Kleisman MM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Sonneveld E; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Buijs-Gladdines JGC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Hagleitner MM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Veening MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Beishuizen A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Meijerink JPP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Present address: Acerta-Pharma (AstraZeneca) Oss The Netherlands.; Loeffen JLC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Kuiper RP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Department of Genetics University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Kroeze E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kleisman MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Hagelaar R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Bladergroen RS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van Dijk F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.; Loeffen JLC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Academic Journal
Kemps PG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Tousseyn T; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Translational Cell and Tissue Research Laboratory, Catholic University of Leuven, Leuven, Belgium.; Vanden Bempt I; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.; Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dors N; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Jazet IM; Department of Internal Medicine, Section Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.; Limper M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Jak M; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Donker ML; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; de Jonge NA; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; van Noesel CJM; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Pathology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Hebeda KM; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van Dorp S; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Tonino SH; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; van Laar JAM; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Internal Medicine, Section Clinical Immunology and Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; van Halteren AGS; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; HOVON Histiocytic and Lymphocytic Diseases Working Group, Rotterdam, The Netherlands.; Department of Internal Medicine, Section Clinical Immunology and Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Academic Journal
Rutgers JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Bánki T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Utrecht University, Utrecht, The Netherlands.; van der Kamp A; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; University of Groningen, Groningen, The Netherlands.; Waterlander TJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Utrecht University, Utrecht, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; van der Laak JAWM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Fiocco M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Mathematical Institute Leiden University, Leiden, The Netherlands.; Medical Statistics, Biomedical Data Science Department, Leiden University Medical Center, Leiden, The Netherlands.; Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. r.r.dekrijger-2@prinsesmaximacentrum.nl.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. r.r.dekrijger-2@prinsesmaximacentrum.nl.
Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596 (Electronic) Linking ISSN: 17461596 NLM ISO Abbreviation: Diagn Pathol Subsets: MEDLINE
Academic Journal
Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.wienke-4@prinsesmaximacentrum.nl.; Visser LL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Kholosy WM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Barisa M; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.; Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Munnings-Tomes S; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.; Himsworth C; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.; Calton E; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Rodriguez A; Hoffman-La Roche, Basel, Switzerland.; Bernardi R; Genentech, A Member of the Roche Group, South San Francisco, CA, USA.; van den Ham F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Matser YAH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Tas ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Borst AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Zappa E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Bergsma FJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Strijker JGM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Verhoeven BM; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Mei S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.; Kramdi A; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Restuadi R; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Sanchez-Bernabeu A; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands.; Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Gray JC; Centre for Cancer Immunology, University of Southampton, Southampton, UK.; Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Straathof K; University College London (UCL) Great Ormond Street Institute of Child Health, London, UK; UCL Cancer Institute, London, UK.; Behjati S; Wellcome Sanger Institute, Hinxton, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Wu W; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pharmacy, National University of Singapore, Singapore, Singapore.; Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands.; Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, the Netherlands.; Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Janoueix-Lerosey I; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Baryawno N; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Anderson J; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK; Department of Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, England, UK.; Caron HN; Hoffman-La Roche, Basel, Switzerland.; Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Utrecht, the Netherlands.; Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Westera L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Tops BBJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Electronic address: f.meyer-wentrup@prinsesmaximacentrum.nl.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE
Academic Journal
Kemps PG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Zondag TCE; Department of Internal Medicine/Clinical Immunology, Erasmus Medical Center (Erasmus MC), Rotterdam, The Netherlands.; Arnardóttir HB; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Medical University of Vienna, Vienna, Austria.; Solleveld-Westerink N; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Borst J; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.; Steenwijk EC; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.; van Egmond D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Swennenhuis JF; Cergentis BV, Utrecht, The Netherlands.; Stelloo E; Cergentis BV, Utrecht, The Netherlands.; Trambusti I; Pediatric Hematology/Oncology Department, Meyer Children's University Hospital, Florence, Italy.; Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; van Noesel CJM; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Cleven AHG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Koudijs MJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Krsková L; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.; Hawkins C; Department of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.; Egeler RM; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.; Brok J; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; von Bahr Greenwood T; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Svojgr K; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.; Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands.; van Laar JAM; Department of Internal Medicine/Clinical Immunology, Erasmus Medical Center (Erasmus MC), Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; Pötschger U; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Medical University of Vienna, Vienna, Austria.; Hutter C; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Medical University of Vienna, Vienna, Austria.; Sieni E; Pediatric Hematology/Oncology Department, Meyer Children's University Hospital, Florence, Italy.; Minkov M; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Medical University of Vienna, Vienna, Austria.; Abla O; Department of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.; van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; van Halteren AGS; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaximacentrum.nl.; Meister MT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Oncode Institute, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Bakhuizen JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Boer JM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Hulleman E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Ilan U; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Looze EJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Breunis W; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Universitäts-Kinderspital Zürich, Steinwiesstrasse 75, 8032 Zürich, Switzerland.; Schild LG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Ober K; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; van Hooff SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Flucke UE; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Kranendonk MEG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Wesseling P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Sonneveld E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Punt S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Boltjes A; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; van Dijk F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Verwiel ETP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Volckmann R; Department of Oncogenomics, Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.; Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Koudijs MMJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Waanders E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Holstege FCP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Vormoor HJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Universitäts-Kinderspital Zürich, Steinwiesstrasse 75, 8032 Zürich, Switzerland; Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK.; Hoving EW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; van Noesel MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Pieters R; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Kool M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Stumpf M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Blattner-Johnson M; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Balasubramanian GP; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Pediatric Hematology and Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.; Jones BC; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Pediatric Hematology and Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Pediatric Hematology and Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Pediatric Hematology and Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.; Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Kuiper RP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Wijnen MHW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; den Boer ML; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Zwaan CM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Kemmeren P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.; Koster J; Department of Oncogenomics, Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.; Tops BBJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Goemans BF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Zijtregtop EAM; Department of Pediatric Hematology and Oncology, Erasmus Medical Center-Sophia Children's Hospital, 3015 GD Rotterdam, The Netherlands.; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; van der Strate I; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Beishuizen A; Department of Pediatric Hematology and Oncology, Erasmus Medical Center-Sophia Children's Hospital, 3015 GD Rotterdam, The Netherlands.; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Zwaan CM; Department of Pediatric Hematology and Oncology, Erasmus Medical Center-Sophia Children's Hospital, 3015 GD Rotterdam, The Netherlands.; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Scheijde-Vermeulen MA; Department of Pathology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Brandsma AM; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Meyer-Wentrup F; Department of Pediatric Hemato-oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Scheijde‐Vermeulen, Marijn A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어